Project Details
Description
A Two Arm Randomized Open Label Phase 2 Study of CP-751,871 Combination with Exemestane versus Exemestane Alone as First Line Treatment of Postmenopausal
| Status | Finished |
|---|---|
| Effective start/end date | 2/18/07 → 6/30/14 |
Funding
- SYNEOS HEALTH, INC
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.